San Diego, CA, United States of America

Sak Khammungkhune


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):

Title: Inventor Profile: Sak Khammungkhune

Introduction

Sak Khammungkhune is an innovative inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly through his work on estrogen receptor modulation. With a total of three patents to his name, Khammungkhune continues to push the boundaries of scientific research and development.

Latest Patents

Khammungkhune's latest patents focus on compounds and methods for the modulation of estrogen receptors. These patents disclose compounds that are designed to modulate gene expression through the estrogen receptor (ER), and they include both the chemical structures of these compounds as well as pharmaceutical compositions containing them. His research addresses important biochemical processes that can have a substantial impact on various health conditions.

Career Highlights

Sak Khammungkhune currently works at Signal Pharmaceuticals, Inc., a company known for its innovative approaches in the pharmaceutical industry. His career is marked by a commitment to developing new therapeutic strategies that enhance the understanding and treatment of diseases influenced by estrogen receptors.

Collaborations

Throughout his career, Khammungkhune has collaborated with esteemed colleagues, including Shripad S Bhagwat and Jeffrey A McKie. These partnerships have fostered a dynamic research environment that encourages the sharing of ideas and the pursuit of scientific excellence.

Conclusion

Sak Khammungkhune's contributions to the field of pharmacology and his innovative patents position him as a significant figure in the research community. As he continues his work at Signal Pharmaceuticals, Inc., his advancements in estrogen receptor modulation are anticipated to pave the way for new therapeutic options and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…